Clinical Trial Detail

NCT ID NCT03568422
Title CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications

Her2-receptor negative breast cancer

Therapies

CFI-402257 + Paclitaxel

Age Groups: senior adult

Additional content available in CKB BOOST